The Usefulness of Gastric Mass Screening Using Serum Pepsinogen Levels Compared with Photofluorography
Hiroshima Journal of Medical Sciences 46 巻 2 号
81-86 頁
1997-06 発行
アクセス数 : 1479 件
ダウンロード数 : 171 件
今月のアクセス数 : 7 件
今月のダウンロード数 : 0 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00037821
ファイル情報(添付) |
HiroshimaJMedSci_46_81.pdf
528 KB
種類 :
全文
|
タイトル ( eng ) |
The Usefulness of Gastric Mass Screening Using Serum Pepsinogen Levels Compared with Photofluorography
|
作成者 |
Sumii Koji
Haruta Ken
Kiyohira Kuninushi
Hattori Nobuaki
Kajiyama Goro
Shigenobu Takuso
|
収録物名 |
Hiroshima Journal of Medical Sciences
|
巻 | 46 |
号 | 2 |
開始ページ | 81 |
終了ページ | 86 |
収録物識別子 |
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
|
抄録 |
Chronic atrophic gastritis, which is thought to be a high risk for gastric cancer, can be diagnosed by serum pepsinogen levels. We compared the usefulness of the measurement of pepsinogen levels and indirect photofluorography as indicators of gastric cancer in a mass screening involving 5,620 Japanese subjects (mean age: 60.1 years old; male : female = 2,268 : 3,352) in 1991 and 1992. Subjects with a serum pepsinogen I level below 30 μg/liter or a pepsinogen I/II ratio below 2.0 were considered to be at high risk of gastric cancer. The incidence of gastric cancer and the ratio of early cancers detected by pepsinogen levels (0.12%, 4/7) were similar to those detected by photofluorography (0.11 %, 4/6). Our results showed that mass screening using pepsinogen levels was as useful as indirect photofluorography for the detection of gastric cancer in Japan. In addition, our results showed that the sensitivity of gastric mass screening was increased when the measurement of serum pepsinogen levels was combined with photofluorography.
|
著者キーワード |
Serum pepsinogen
Gastric mass screening
Gastric cancer
Photofluorography
|
NDC分類 |
医学 [ 490 ]
|
言語 |
英語
|
資源タイプ | 紀要論文 |
出版者 |
Hiroshima University Medical Press
|
発行日 | 1997-06 |
出版タイプ | Version of Record(出版社版。早期公開を含む) |
アクセス権 | オープンアクセス |
収録物識別子 |
[ISSN] 0018-2052
[NCID] AA00664312
|